Pharmaceutical & Cosmetics
World leader in aspirin, ketamine, salicylic acid and its derivatives and methimazole. Number two worldwide in para-aminophenol and number three in paracetamol in Europe. Novacap is also a recognised leader in custom synthesis.
The Pharmaceutical & Cosmetics division manufactures and distributes active pharmaceutical ingredients (APIs) as well as specialty chemicals mainly used as intermediates in the pharmaceutical and cosmetics industries. The division operates on a global scale of key end-markets such as pharmaceutical, health, cosmetics, and fragrances.
The division includes 4 business units: Novacyl, Uetikon, Puyuan, and Yangzi. With 7 production sites (5 cGMP production sites), the division employs 1100 people worldwide.
Novacyl is the world’s number one in salicylic acid and aspirin.
Novacyl is a unique integrated player with a strong industrial footprint in France, Brazil and China and Novacyl is the world leader in salicylic acid and acetylsalicylic acid. Novacyl is number two for paracetamol in Europe. Read more about Novacyl
CU Chemie Uetikon, a highly differentiated actor in CMO, complex small-molecules APIs and registered intermediates is part of Novacap’s Pharmaceutical & Cosmetics division.
Founded in 1991, Uetikon is a medium-sized company with a best-in-class multi-purpose production facility. This cGMP production facility, which was built to a high standard, is located in Lahr, Germany. CU Chemie Uetikon has been part of Novacap’s Pharmaceutical & Cosmetics division since 2015. Read more about Uetikon
Taixing Yangzi Pharm Chemical Co Ltd, a joint-venture between the Novacap group and its managers, is the global number two in para-aminophenol (PAP), a key ingredient for the production of paracetamol.
In 2017, Novacap increased its majority shareholding in Yangzi, located in the Taixing Economic Development Zone, in Shanghai. Taixing is one of the leading Chinese producers of para-aminophenol (“PAP”), a chemical intermediate mainly used for the production of paracetamol. Yangzi’s technology and its products are widely recognised in the pharmaceuticals industry as the benchmark in terms of quality and purity. The production site employs more than 380 people, mainly engineers and technicians.
Jiangsu Puyuan Chemical Co is specialised in salicylic acid and methyl salicylate production
Since 2014, the company has been majority owned by Novacap and is part of the group’s Pharmaceutical & Cosmetics division. Located in the Chinese province of Jiangsu, in Zhenjiang, Puyuan is a major player in the production of salicylic acid and methyl salicylate, key intermediates in cosmetic applications, fragrances, epoxy resins and other industrial applications. The company employs approximately 150 people.
Key figures :
1 100 employees
8 production sites (5 cGMP production sites)
Global leader for aspirin, ketamine and salicylic acid
Global no. 2 for para-aminophenol
European no. 3 for paracetamol